170 related articles for article (PubMed ID: 37318257)
41. Comparison of organ-specific endothelial cells in terms of microvascular formation and endothelial barrier functions.
Uwamori H; Ono Y; Yamashita T; Arai K; Sudo R
Microvasc Res; 2019 Mar; 122():60-70. PubMed ID: 30472038
[TBL] [Abstract][Full Text] [Related]
42. Three-dimensional induced pluripotent stem-cell models of human brain angiogenesis.
Linville RM; Arevalo D; Maressa JC; Zhao N; Searson PC
Microvasc Res; 2020 Nov; 132():104042. PubMed ID: 32673611
[TBL] [Abstract][Full Text] [Related]
43. Presence of a mutation in PSEN1 or PSEN2 gene is associated with an impaired brain endothelial cell phenotype in vitro.
Raut S; Patel R; Al-Ahmad AJ
Fluids Barriers CNS; 2021 Jan; 18(1):3. PubMed ID: 33413468
[TBL] [Abstract][Full Text] [Related]
44. Differentiating embryonic neural progenitor cells induce blood-brain barrier properties.
Weidenfeller C; Svendsen CN; Shusta EV
J Neurochem; 2007 Apr; 101(2):555-65. PubMed ID: 17254017
[TBL] [Abstract][Full Text] [Related]
45. Three-dimensional microenvironment regulates gene expression, function, and tight junction dynamics of iPSC-derived blood-brain barrier microvessels.
Linville RM; Sklar MB; Grifno GN; Nerenberg RF; Zhou J; Ye R; DeStefano JG; Guo Z; Jha R; Jamieson JJ; Zhao N; Searson PC
Fluids Barriers CNS; 2022 Nov; 19(1):87. PubMed ID: 36333694
[TBL] [Abstract][Full Text] [Related]
46. Prediction of Drug Permeability Using
Ohshima M; Kamei S; Fushimi H; Mima S; Yamada T; Yamamoto T
Biores Open Access; 2019; 8(1):200-209. PubMed ID: 31737437
[TBL] [Abstract][Full Text] [Related]
47. TGF-β and SHH Regulate Pluripotent Stem Cell Differentiation into Brain Microvascular Endothelial Cells in Generating an In Vitro Blood-Brain Barrier Model.
Lee NG; Lim MH; Park J; Jeung IC; Hwang B; Lee J; Park JG; Son MY; Han BS; Yoon SJ; Lee SJ; Park YJ; Kim JH; Lee NK; Lee SC; Min JK
Bioengineering (Basel); 2023 Sep; 10(10):. PubMed ID: 37892862
[TBL] [Abstract][Full Text] [Related]
48. Human iPSC-derived brain endothelial microvessels in a multi-well format enable permeability screens of anti-inflammatory drugs.
Fengler S; Kurkowsky B; Kaushalya SK; Roth W; Fava E; Denner P
Biomaterials; 2022 Jul; 286():121525. PubMed ID: 35599022
[TBL] [Abstract][Full Text] [Related]
49. Induced pluripotent stem cell-derived cells model brain microvascular endothelial cell glucose metabolism.
Weber CM; Moiz B; Zic SM; Alpízar Vargas V; Li A; Clyne AM
Fluids Barriers CNS; 2022 Dec; 19(1):98. PubMed ID: 36494870
[TBL] [Abstract][Full Text] [Related]
50. Directed differentiation of human pluripotent stem cells to blood-brain barrier endothelial cells.
Qian T; Maguire SE; Canfield SG; Bao X; Olson WR; Shusta EV; Palecek SP
Sci Adv; 2017 Nov; 3(11):e1701679. PubMed ID: 29134197
[TBL] [Abstract][Full Text] [Related]
51. SARS-CoV-2 causes dysfunction in human iPSC-derived brain microvascular endothelial cells potentially by modulating the Wnt signaling pathway.
Yamada S; Hashita T; Yanagida S; Sato H; Yasuhiko Y; Okabe K; Noda T; Nishida M; Matsunaga T; Kanda Y
Fluids Barriers CNS; 2024 Apr; 21(1):32. PubMed ID: 38584257
[TBL] [Abstract][Full Text] [Related]
52. Blood-brain barrier modeling with co-cultured neural progenitor cell-derived astrocytes and neurons.
Lippmann ES; Weidenfeller C; Svendsen CN; Shusta EV
J Neurochem; 2011 Nov; 119(3):507-20. PubMed ID: 21854389
[TBL] [Abstract][Full Text] [Related]
53. The role of mutations associated with familial neurodegenerative disorders on blood-brain barrier function in an iPSC model.
Katt ME; Mayo LN; Ellis SE; Mahairaki V; Rothstein JD; Cheng L; Searson PC
Fluids Barriers CNS; 2019 Jul; 16(1):20. PubMed ID: 31303172
[TBL] [Abstract][Full Text] [Related]
54. A genomic comparison of in vivo and in vitro brain microvascular endothelial cells.
Calabria AR; Shusta EV
J Cereb Blood Flow Metab; 2008 Jan; 28(1):135-48. PubMed ID: 17565361
[TBL] [Abstract][Full Text] [Related]
55. Reprogramming of Adult Peripheral Blood Cells into Human Induced Pluripotent Stem Cells as a Safe and Accessible Source of Endothelial Cells.
Simara P; Tesarova L; Rehakova D; Farkas S; Salingova B; Kutalkova K; Vavreckova E; Matula P; Matula P; Veverkova L; Koutna I
Stem Cells Dev; 2018 Jan; 27(1):10-22. PubMed ID: 29117787
[TBL] [Abstract][Full Text] [Related]
56. Nuclear receptor ligand screening in an iPSC-derived in vitro blood-brain barrier model identifies new contributors to leptin transport.
Shi Y; Kim H; Hamann CA; Rhea EM; Brunger JM; Lippmann ES
Fluids Barriers CNS; 2022 Sep; 19(1):77. PubMed ID: 36131285
[TBL] [Abstract][Full Text] [Related]
57. Prolonged culturing of iPSC-derived brain endothelial-like cells is associated with quiescence, downregulation of glycolysis, and resistance to disruption by an Alzheimer's brain milieu.
Williams LM; Fujimoto T; Weaver RR; Logsdon AF; Evitts KM; Young JE; Banks WA; Erickson MA
Fluids Barriers CNS; 2022 Feb; 19(1):10. PubMed ID: 35123529
[TBL] [Abstract][Full Text] [Related]
58. Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening.
Wang YI; Abaci HE; Shuler ML
Biotechnol Bioeng; 2017 Jan; 114(1):184-194. PubMed ID: 27399645
[TBL] [Abstract][Full Text] [Related]
59. Appearance of claudin-5
Paul D; Baena V; Ge S; Jiang X; Jellison ER; Kiprono T; Agalliu D; Pachter JS
J Neuroinflammation; 2016 Nov; 13(1):292. PubMed ID: 27852330
[TBL] [Abstract][Full Text] [Related]
60. A stable and reproducible human blood-brain barrier model derived from hematopoietic stem cells.
Cecchelli R; Aday S; Sevin E; Almeida C; Culot M; Dehouck L; Coisne C; Engelhardt B; Dehouck MP; Ferreira L
PLoS One; 2014; 9(6):e99733. PubMed ID: 24936790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
